An elderly woman with anti-neutrophil antibody-positive agranulocytosis who responded to high-dose intravenous methylprednisolone

1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Although anti-neutrophil antibodies (ANAs) often exist and immunoreaction may be involved in agranulocytosis, few reports have so far described ANA-positive cases of agranulocytosis with an unknown etiology. We herein describe the case of a 69-year-old woman who presented with ANA-positive agranulocytosis. In this case, both the withdrawal of the drugs that had possibly caused neutropenia and the use of granulocyte-colony stimulating factor (G-CSF) were ineffective treatment measures. Approximately 2 weeks after the discontinuation of the suspected drugs, we initiated corticosteroid pulse therapy; the neutrophil count recovered by day 19 of steroid therapy. High-dose methylprednisolone therapy should thus be considered for patients demonstrating ANA-positive agranulocytosis with an unknown etiology that is refractory to G-CSF treatment.

Cite

CITATION STYLE

APA

Koh, S., Koh, H., Kubo, Y., Kuroda, M., Nishimoto, M., Yoshimura, T., … Hino, M. (2017). An elderly woman with anti-neutrophil antibody-positive agranulocytosis who responded to high-dose intravenous methylprednisolone. Internal Medicine, 56(16), 2199–2203. https://doi.org/10.2169/internalmedicine.8268-16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free